U.S. Luxury Stock News

SIGA Technologies (SIGA) has just wrapped up FY 2025 with a mixed earnings print, as fourth quarter revenue came in at about US$3.8 million and basic EPS landed at a loss of US$0.08, while the trailing 12 month figures show total revenue of roughly US$94.6 million and basic EPS of US$0.33. The company has seen quarterly revenue move from US$81.5 million in Q4 2024 to US$81.1 million in Q2 2025 before easing back to US$3.8 million in Q4 2025, with EPS shifting from US$0.64 in Q4 2024 to...

Biotech sentiment has improved following an FDA leadership change that investors view as easing regulatory hurdles for cell and gene therapies. PTC Therapeutics, listed as NasdaqGS:PTCT, is among the companies seen as directly affected by this shift in perceived regulatory risk. The change centers on the departure of an official viewed as cautious on accelerated approvals, which is drawing fresh attention to PTC's drug pipeline. For PTC Therapeutics, trading at $65.67, this regulatory...

Kennametal executive Ellen Whittingham has been named a 2026 STEP Ahead Award Honoree. The award recognizes her leadership and work in talent development within the manufacturing sector. This recognition highlights Kennametal's focus on workplace culture and leadership depth at NYSE:KMT. Kennametal, listed on NYSE:KMT, supplies tooling and industrial materials to customers across metalworking and related manufacturing fields. Recognition for an executive focused on leadership and talent...

Packaging Corporation of America recently reported quarterly revenue of US$2.36 billion, up 10.1% year on year but below analyst expectations, while also announcing the planned retirement of long-serving director Paul T. Stecko, the promotion of Fabian C. Strauss to Senior Vice President Finance, Controller & Treasurer, and facing a new California labor class action over alleged rest and meal break violations. Together, the earnings shortfall against forecasts, leadership transition in the...

Ingram Micro Holding (INGM) recently secured two U.S. patents tied to its Xvantage platform, a step that underlines its platform-focused approach and could matter for how investors think about the business. See our latest analysis for Ingram Micro Holding. The share price has been choppy around the current US$22.50 level, with a 7 day share price return of a 14.42% decline, a 30 day share price return of 5.04% and a 1 year total shareholder return of 20.41%. This suggests recent momentum has...

In February 2026, Interface, Inc. expanded its rubber flooring portfolio with noravant™, a first-of-its-kind PVC-free resilient solution that combines high performance, woodgrain design, and a low carbon footprint, initially launched as noravant timber in the Americas and select EMEA markets. The product’s multi-layer construction, industry-first woodgrain rubber aesthetic, and recyclability through Interface’s take-back program highlight how design flexibility and circularity are becoming...

Why Sharplink Is Drawing Investor Attention Now Sharplink (SBET) has been on many watchlists after a 14.1% gain over the past month, set against a 27.8% decline over the past 3 months that keeps recent volatility front and center. See our latest analysis for Sharplink. Sharplink’s recent bounce, including a 14.1% 30 day share price return, comes after a tougher period and leaves the stock at US$7.59, with a 1 year total shareholder return of 75.4% but a 3 year total shareholder return that...

If you are wondering whether Rithm Capital’s current share price reflects its true worth, you are not alone, especially with income focused financial stocks back on many watchlists. The stock last closed at US$9.87, with returns of 1.1% over 7 days but declines of 7.3% over 30 days, 10.1% year to date, and 5.7% over 1 year. However, the 3 year and 5 year returns of 64.6% and 41.6% show a very different picture for longer term holders. Recent coverage has focused on Rithm Capital’s position...

What FuelCell Energy’s Latest Earnings Tell You FuelCell Energy (FCEL) just reported Q1 2026 results, with revenue of US$30.53 million, sales of US$10.99 million, and a net loss of US$22.86 million, alongside a smaller loss per share year over year. See our latest analysis for FuelCell Energy. FuelCell Energy’s shares have been under pressure despite the Q1 2026 revenue lift and narrower loss. The 7 day share price return shows a 17.04% decline and the 90 day share price return shows an...

Blend Labs (BLND) just posted its FY 2025 fourth quarter numbers, with revenue of US$32.4 million and a basic EPS loss of US$0.03, while net income excluding extra items came in at a loss of US$7.1 million. The company has seen quarterly revenue move from US$41.4 million in Q4 2024 to US$32.4 million in Q4 2025, with basic EPS shifting from a loss of US$0.03 in Q4 2024 to a loss of US$0.03 in the latest quarter. As a result, this reporting period is likely to draw attention to how the loss...

If you are wondering whether Costamare's current share price offers value or risk, this article walks through what the numbers actually say about the stock. Over the past year, Costamare's share price return stands at 126.4%, with a 7.1% return year to date and 4.4% over the last 30 days, while the most recent 7 day period shows a 3.7% decline. Recent news around shipping, charter rates, and trade flows has kept attention on container ship and dry bulk owners. This has put companies like...

If you are wondering whether Qualys shares are starting to look interesting, this article will walk through how the current price lines up against the underlying business. The stock last closed at US$96.66, with returns of a 1.4% decline over 7 days, an 11.4% decline over 30 days, a 26.2% decline year to date, and a 21.5% decline over the past year, which may influence how investors are thinking about both growth potential and risk. Over the past few months, Qualys has continued to feature...

If you are wondering whether Fabrinet's recent share price puts it on your watchlist or on the too-expensive pile, it helps to first pin down what you are actually paying for today. The stock last closed at US$524.33, after a 7 day return of a 7.0% decline, a 30 day return of 4.5%, a year to date return of 9.4% and a 1 year return of 159.7%, with the 3 year return at 362.2% and the 5 year figure very large compared to the starting point. Recent price moves have been accompanied by ongoing...

If you are wondering whether Strategic Education's current share price still represents solid value, the recent data gives you plenty to think about. The stock closed at US$78.87 recently, with returns of a 3.3% decline over 7 days and a 1.3% decline over 30 days, while year to date it is up 0.4% and the 1-year return sits at 1.6%. These steady but modest return figures over the past year, including 0.8% over 3 years and 4.6% over 5 years, suggest the market has been cautious in how it...

Elevance Health (NYSE:ELV) has signed new network participation agreements with Myomo, Inc. The deals extend in-network coverage for Myomo’s FDA cleared orthopedic devices to Elevance’s roughly 45 million Commercial, Medicare Advantage, and Medicaid members nationwide. For you as an investor, this ties directly into how NYSE:ELV positions itself as a broad based health benefits and services company. Elevance already spans commercial employer plans, government programs, and related health...

Global Business Travel Group (NYSE:GBTG) has completed its acquisition of CWT, reaching what management calls an inflection point in its business transformation. The company is rolling out Egencia AI, which management says is already contributing to measurable revenue and cost efficiencies. GBTG reports strong revenue growth and profitability in 2025 alongside accelerated integration, restructuring, and productivity efforts. For investors watching NYSE:GBTG, the share price at $5.57 sits...

Transocean has completed an all stock acquisition of Valaris, combining two major offshore drilling companies. The deal significantly expands Transocean's offshore rig fleet and contract portfolio. Management expects cost synergies and a stronger competitive position in the global offshore drilling market. For investors watching NYSE:RIG, this merger follows a period of strong share price moves, with the stock up 48.8% year to date and 111.7% over the past year, closing at $6.31. The...

If you are wondering whether Preformed Line Products is still offering value after a strong run, this article walks through what the current share price might be implying about the business. The stock closed at US$267.23 recently, with returns of 4.6% over 7 days, a 2.5% decline over 30 days, 26.1% year to date and 118.3% over the past year, as well as 135.3% over 3 years and 271.3% over 5 years. Recent attention on grid reliability, utility infrastructure and related capital projects has...

Wells Fargo has filed a trademark application for "WFUSD," indicating potential plans to offer digital asset and cryptocurrency services. The filing points to possible products such as crypto trading, exchange services, payment processing, and digital asset wallets. This move would represent an expansion of Wells Fargo's role in the growing crypto and blockchain segment of financial services. Shares of Wells Fargo (NYSE:WFC) last closed at $76.88, with the stock showing a 14.0% return over...

Lantronix (LTRX) is back on investor radars after expanding its embedded compute portfolio with new MediaTek based System on Module solutions and signing a European distribution deal with Melchioni Electronics. See our latest analysis for Lantronix. The recent MediaTek based SOM launch and the Melchioni distribution deal arrive after a mixed stretch for the stock, with a 7 day share price return of 3.89% but a 90 day share price return decline of 6.69%, while the 1 year total shareholder...

uniQure (NasdaqGS:QURE) faces multiple securities class action lawsuits focused on disclosures around its AMT-130 gene therapy program. Federal health officials have criticized the company for alleged data manipulation tied to AMT-130. The FDA has withdrawn support for a Biologics License Application for AMT-130, complicating the program's regulatory path. Upcoming changes in FDA leadership are expected to affect how AMT-130 and related filings are reviewed. These developments arrive at a...

If you are wondering whether Amdocs is starting to look like value after a weaker share price, this article will help you weigh what the current price actually offers you. The stock last closed at US$66.92, with returns of a 2.6% decline over 7 days, an 8.8% decline over 30 days, a 16.5% decline year to date, and a 21.6% decline over the past year. Recent coverage around Amdocs has focused on its role as a software and services provider to telecom and media companies. This keeps attention on...

Servier Pharmaceuticals has entered into a definitive agreement to acquire Day One Biopharmaceuticals, NasdaqGS:DAWN, in an all cash transaction. The deal marks a material change in ownership, bringing Day One Biopharmaceuticals under Servier control and ending its status as an independent company once the transaction closes. Day One Biopharmaceuticals focuses on developing and commercializing oncology therapies, a segment that has seen frequent partnerships, licensing arrangements, and...

If you are wondering whether Microchip Technology is still good value after its recent run, this article will walk through what the current share price could mean for long term investors. The stock trades at US$65.79, with recent returns showing a 5.9% decline over 7 days, an 11.6% decline over 30 days, but a 30.6% gain over the past year and a 1.2% return year to date. Recent coverage around Microchip Technology has focused on its position in the semiconductor space and how investor...